throbber
Remington: The
`% Sci;éric0e0a0i%hd Practice
`*
`0 .
`Pharmacy
`
`Volume I
`
`MYLAN ET AL. - EXHIBIT 1013
`
`0001
`
`MYLAN ET AL. - EXHIBIT 1013
`
`0001
`
`

`
` Remington: The
`
`Sc[iénce*a‘né| Practice
`5 of Pharmacy
`
`Volume II
`
`
`
`5......__
`
`0002
`
`0002
`
`

`
`Entered according to Act of Congress, in the year l88’5 by Joseph P Remington,
`in the Ofiice of the Librarian of Congress, at Washington DC
`.
`
`Copyright 1889, 1394, 1905, 1907,19'17, byJosephPRemihgtoh
`
`Copyright 1 926, 1936, by the Joseph P Remington Estate
`
`Copyright 1948, 1 95 1, by The Philadelphia College of Pharmacy and Science
`
`Copyright 1956, 1960, 1965,1970, 1975, 1980, 1985, 1990, 1995, by The Philatlelphia College. of
`Pharmacy and Science
`
`All Rights Reserved
`
`Library of Congress Catalog Card No. 60-53334
`
`ISBN O-912734-O4-3
`
`The use ofstructuralformulasfrom USAN and the USP Dictionary ofDrug Names is by
`permission ofThe USP Convention. The Convention is not responsiblefor any inaccuracy
`contained herein.
`
`NOTICE—This text is not intended to represent, nor shall it be interpreted to be, the equivalent
`ofor a substitntefor the oficial United States Pharmacopeia (USP) and / or the National
`Formnlary (NF). In the event ofany difference or discrepancy between the current ofiicial
`USP 0rNF standards ofstrength, quality, purity, packaging and labelingfor drugs and
`representations ofthem herein, the context and efiect ofthe ofiicial compenolia shall prevail.
`
`Printed in the United States of/lmerica by the Mach Printing Company, Easton, Pennsylvania
`
`0003
`
`

`
`CHAPTER36
`
`Tonicity, Osn1oticity,.Osmolali_fy and Qsmolcirity
`
`Irwin Reich, BS:
`Instructor and Manager, Pharmacy Laboratory
`
`lulouger Schnoore, PhD
`Professor of Pharmacy
`
`Basic Definitions
`
`If a‘ solution is placed incontact with’ a membranethat is
`permeable to molecules of the solvent, but not to molecules of
`the solute, the movement of solvent through the membrane is
`called osmosis. Such a membrane often is called semi-
`permeable. As the several types of membranes of the body
`vary in their permeability,
`it is well to note that they are
`selectively permeable. Most" normal living-cell membranes
`maintain various solute concentration gradients. A selec-
`tively permeable membrane may be defined either as one that
`does not permit free, unhampered diffusion of all the solutes
`present, or as one that ‘maintains at least one solute concentra-
`tion gradient across itself. Osmosis, then, is the diffusion of
`water through a membrane that maintains at least one solute
`concentrdtigngradient across itself.
`,
`T
`‘
`AssuméS,§olution A is on one side of themembrane, and
`Solution Bqbf the same solute but of a higher concentration is
`on the other side; the solvent will tend to ‘pass into the more
`concentrated solution until equilibrium has been established.
`The pressure required to prevent this movement is the os-
`motic pressure.
`It is definedas the excess pressure, or pres-
`sure greater than that above the pure solvent, ‘which must be
`applied to Solution B to prevent passage of solvent through a
`perfect semipermeable membrane from A to B. The concen-
`tration of a solution with respect to effect on .osmotic pressure
`is related to the number of particles (unionized molecules,
`ions, macromolecules, aggregates) of solute(s) in solution
`and thus is affected byvthe degree of ionizatiorior aggregation
`of the solute. ' See Chapter 16 for review of colligative prop-
`erties of solutions.
`V
`T
`'
`V
`Body fluids, including blood and lacrimal fluid, normally
`have an osmoticpressure which often is described as corre-
`sponding to that of a 0.9% solution of sodium chloride. The
`body also attempts to keep the osmotic pressure of the con-
`tents of the gastrointestinal tract at about this level, but there
`the norma ange is much wider than that of most body fluids.
`The 0.9% sodium chloride solution is said to be 7330-‘osmotic
`with physiological fluids. The term isotonic, meaning equal
`tone, is in medical usage commonly used interchangeably
`with isoosmotic. However, terms such as isotonic and tonic-
`ity should be used, only with reference to a physiologic fluid.
`Isoosmotic actually is a physical term which compares the
`osmotic pressure (or another colligative property, such as
`freezing-point depression) of two liquids, neither of which
`may be_a physiological fluid, or which may be aphysiological
`fluid only under certain circumstances. For example, a solu-
`tion of boric acid that is isoosmotic with both blood and
`lacrimal fluid is isotonic only with the lacrimal fluid. This
`solution causes hemolysis of red blood cells because mol-
`ecules of boric acid pass freely through the erythrocyte mem-
`brane regardless of concentration.
`- Thus, isotonicity infers a
`sense of physiological compatibility where isoosmoticity need
`
`Edwin ‘l' Sugita, PhD
`Professor and Chairman, Pharmaceutics Dept
`Philadelphia College of Phurrnocy_orid Science
`Philadelphia, PA 19104
`‘
`
`another example, a. .“chemically defined elemental
`not. ,‘
`diet” or enteral nutritional fluid can be iso-osmotic with the
`contents of the gastrointestinal tract, but would not be consid-
`-ered a physiological fluid,‘or, suitable for parenteral use.
`_A solution is isotonic with a living cell if there is no net gain
`'or loss. of water by the cell, or other change in the.cell when it is
`in contact with that solution. Physiological solutions with an
`osmotic pressure lower than that of body fluids, or of 0.9%
`sodium chloride solution, are referred to commonly as being
`hypotonic. Physiological solutions having agreater osmotic
`pressure are termed hypertonic.
`,
`T
`.
`Such qualitative terms are of limited value, and it has
`become necessary to state osmotic properties in quantitative
`terms. - To do so, a term must be used that will represent all
`the particles which may be present in a given system. The
`term used is osmol. An osmol is defined as the weight, in
`grams, of a solute, existing in a solution as molecules (and/or
`ions, macromolecules, aggregates, etc), which is osmotically
`equivalent to a mole of an ideally behaving nonelectrolyte.
`Thus, the osmol‘-weight of anonelectrolyte, in a dilute solu-
`tion, generally is equal to its gram-molecular-weight. A mil-
`liosmol, abbreviated mOsm, istheweight stated in milligrams.
`' If one extrapolates this concept of relating an osmol and a
`mole‘ of a nonelectrolyte as being equivalent, then one also
`may define an osmol in the following ways. v It is the amount
`of solutewhich willprovide one Avogadrds number (6102 X
`1O23)'of particles in solution and it is the amount of solute
`which, on dissolution-in 1 kg ofwater, will result in an osmotic
`pressure increase of 17,000 torr at 0° or 19,300vtorr at 37°‘.
`One mOsmol is one-thousandth of an osmol.
`’ For example, 1
`mole of anhydrous dextrose is equal to 180 g. One osmol of
`this nonelectrolyte is also 180 g. One mOsmol would be 180
`mg. Thus 180' mg of this solute dissolved in 1 kg of water will
`produce an increase in osmotic pressure of 19.3 torr at body
`temperature.
`'
`‘
`‘
`For a solution of an electrolyte such as sodium chloride, one
`molecule of sodium chloride represents one sodium and one
`chloride ion. Hence, one mol will represent 2 osmols of
`sodium chloride theoretically. Accordingly, 1 osmol_NaCl =
`58.5 ’_g/2 or 29.25 g. This quantity represents the sum total
`of 6.02 X 1023 ions as the total number of particles.
`Ideal
`solutions infer very dilute solutions or infinite dilution.
`However, as the concentration is increased, other factors
`enter. Withstrong electrolytes, interionic attraction causes
`a decrease in their effect on colligative properties.
`In addi-
`tion,and in opposition, for all solutes, including n0nelectro_-
`lytes, solvation and possibly other factors operate to intensify
`their colligative efiect. Therefore, it is very difficult and of-
`ten impossible to predict accurately the osmoticity of a
`solution.
`It may be possible to do so for a dilute solution of a
`single, pure and well-characterized solute, but not for most
`parenteraland enteral medicinal and/or nutritional fluids;
`experimental determination likely is required.
`
`0004
`
`

`
`614
`
`CHAPTER 36
`
`Therapeutic Considerations
`
`It generally is accepted that osmotic effects have a major
`place in the maintenance of homeostasis (the state of equilib-
`rium in the living body with respect to various functions and to
`the chemical composition ofthe fluids and tissues, eg, tempera-
`ture, heart rate, blood pressure, water content or blood sugar).
`To a great extent these effects occur within or between cells
`and tissues where they cannot be measured. One of the most
`troublesome problems in clinical medicine is the maintenance
`of adequate body fluids and proper balance between extracel-
`lular and intracellular fluid Volumes in seriously _ill patients.
`It should be kept in mind, however, that fluid and electrolyte
`abnormalities are not diseases, but are the manifestations of
`disease.
`The physiological mechanisms which control water intake
`and output appear to respond primarily to serum osmoticity.
`Renal regulation of output is influenced by variation in rate of
`release of pituitary antidiuretic hormone (ADH) and other
`factors in response to changes in serumosmoticity. Osmotic
`changes also serve as a stimulus to moderate thirst. This
`mechanism is sufliciently sensitive to limit variations in osmo-
`ticity in the normal individual to less than about 1%. Body
`fluid continually oscillates within this narrow range. An in-
`crease of plasma osmoticity of 1% will stimulate ADH release,
`result in reduction of urine flow and, at the same time, stimu-
`late thirst that results in increased water intake. Both the
`increased renal reabsorption of water (without solute) stimu-
`lated by circulating ADH and the increased water intake tend
`to lower serum osmoticity.
`The transfer of water through the cell membrane occurs so
`rapidly that any lack of osmotic equilibrium between the two
`fluid compartments in any given tissue usually is corrected
`within a few seconds and, at most, within .a minute or so.
`However, this rapid transfer of water does not mean that
`complete equilibration occurs between the extracellular and
`intracellular compartments throughout the entire body within
`this same short period of time. The reason is that fluid usu-
`ally enters the body through the gut and then must be trans-
`ported by the circulatory system to all tissues before complete
`equilibration can occur.
`In the normal person it may require
`80 to 60 min to achieve reasonably good equilibration through-
`out the body after drinking water. Osmoticity is the property
`that largely determines thephysiologic acceptability of a vari-
`ety of solutions used for therapeutic and nutritional purposes.
`Pharmaceutical and therapeutic consideration of osmotic
`effects has been, to a great extent, directed toward the ‘side
`effects of ophthalmic and parenteral medicinals due to abnor-
`mal osmoticity, and to either formulating to avoid the side
`effects or finding methods of administration to minimize them.
`More recently this consideration has been extended to total
`(central) parenteral nutrition, to enteral hyperalimentation
`(“tube” feeding) and to concentrated-fluid infant formulas.‘
`Also, in recent years, the importance of osmometry of serum
`and urine in the diagnosis of many pathological conditions has
`been recognized.
`There are a number of examples of the direct therapeutic
`effect of osmotic action, such as the intravenous use of manni-
`tol as a diuretic which is filtered at the glomeruli and thus
`increases the osmotic pressure of tubular urine. Water must
`then be reabsorbed against a higher osmotic gradient than
`otherwise, so reabsorption is slower and diuresis is observed.
`The same fundamental principle applies to the intravenous
`administration of 30% urea used to affect intracranial pres-
`sure in the control of cerebral edema. Peritoneal dialysis
`fluids tend to be somewhat hyperosmotic to withdraw water
`an.d nitrogenous metabolites. Two to five percent sodium
`chloride solutions or dispersions in an oleaginous base (Muro,
`Bcmsch & Lamb) and a 40% glucose ointment are used topi-
`cally for corneal edema. Ophthalgan (Wyeth-Ayerst) is oph-
`thalmic glycerin employed for its osmotic effect to clear edema-
`tous cornea to facilitate an ophthalmoscopic or gonioscopic
`examination. Glycerin solutions in 50% concentration [Os-
`moglyn (Al.co'n)] and isosorbide solution [Ismotic (Alco7L)]
`
`are oral osmotic agents for reducing intraocular pressure.
`The osmotic principle also applies to plasma extenders such
`as polyvinylpyrrolidone and to saline laxatives such as magne-
`sium sulfate, magnesium citrate solution, magnesium hydrox-
`ide (via gastric neutralization), sodium sulfate, sodium phos-
`phate and sodium biphosphate oral solution and enema (Fleet).
`- An interesting osmotic laxative which is a nonelectrolyte is
`a lactulose solution. Lactulose is a nonabsorbable disaccha-
`ride which is colon-specific, wherein colonic bacteria degrade
`some of the disaccharide to lactic and other simple organic
`acids. These, in toto, lead to an osmotic effect and laxation.
`An extension ofthis therapy is illustrated by Cephulac (Marion
`Merrell Dow) solution, which uses the acidification of the
`colon via lactulose degradation to serve as a trap for ammonia
`migrating from the blood to the colon. The conversion ‘of
`ammonia of blood to the ammonium ion in the colon ulti-
`mately is coupled with the osmotic effect and laxation, thus
`expelling undesirable levels of blood ammonia. This prod-
`uct is employedto prevent and treat frontal systemic&ncepha-
`lopathy.
`-
`Osmotic laxation is observed with the oral or rectal use of
`glycerin and sorbitol. Epsom salt has been used in baths and
`compresses to reduce edema associated with sprains.
`Another approach is the indirect application of the osmotic
`effect in therapy via osmotic pump drug delivery systems?
`
`Osmolality and Osmolarity
`
`It is necessary to use several additional terms to define
`expressions of concentration in reflecting the osmoticity of
`solutions. The terms include osmolality, the expression of
`osmolal concentration and osmolarity, the expression of osmo-
`lar concentration.
`.
`0smo1ality—A solution has an osmolal concentration of
`one when it contains 1 osmol of solute/kg of water. A solu-
`tion has an osmolality of 71 when it contains Tb osmols/kg of
`water. Osmolalsolutions, like their counterpafltfgnolal solu-
`tions, reflect a weight-to-weight relationship betfgiieen the sol-
`ute and the solvent.
`Since an osmol of any nonéflectrolyte is
`equivalent to 1 mol of that compound, then a 1 osmolal
`solution is synonymous to a 1 molal solution for a typical
`nonelectrolyte.
`.
`With a typical electrolyte like sodium chloride, 1 osmol is
`approximately 0.5 mol of sodium chloride. Thus, it follows
`that a 1 osmolal solution of sodium chloride essentially is
`equivalent to a 0.5 molal solution. Recall that a 1 osmolal
`solution of dextrose or sodium chloride each will contain the
`same particle concentration.
`‘In the dextrose solution there
`will be 6.02 X 1023 molecules/kg of water and in the sodium
`chloride solution one will have 6.02 X 1023 total ions/kg of
`water, one-half of which are Na+ ions and the other half Cl“
`ions.
`As in molal solutions,‘ osmolal solutions usually are em-
`ployed where quantitative precision is required, as in the
`measurement of physical and chemical properties of solutions
`(ie, colligative properties) The advantage of the w/ w rela-
`tionship is that the concentration of the system is not influ-
`enced by temperature.
`’
`Osmolarity——The relationship observed between molality
`and osmolality is shared similarly between molarity and
`osmolarity. A solution has an osmolar concentration of 1
`when it contains 1 osmol of solute/L of solution. Likewise, a
`solution has an osmolarity ofn when it contains at osmols/L of
`solution. Osmolar solutions, unlike osmolal solution, reflect
`a weight in volume relationship between the solute and final
`solution. A 1 molar and '1 osmolar solution would be identi-
`cal for nonelectrolytes. For sodium chloride a 1 osmolar
`solution would contain 1 osmol of sodium chloride per liter
`which approximates a 0.5 molar solution. The advantage of
`employing osmolar concentrations over osmolal concentra-
`tions is the ability to relate a specific number of osmols or
`milliosmols to a volume, such as a liter or mL. Thus, the
`osmolar concept is simpler and more practical. Volumes of
`
`0005
`
`0005
`
`

`
`TONICITY, OSMOTICITY, OSMOLALITY AND OSMOLARITY
`
`615
`
`solution, rather than weights of solution, are more practical in
`the delivery of liquid dosage forms.
`.
`‘
`I
`‘
`r
`‘
`Many health professionals do not have-a clear understand-
`ing of the difference between osmolality and osmolarity.
`In
`fact, the terms have been used interchangeably. A 1 osmolar
`solution of a solute always will be more concentrated than a 1
`osmolal solution. With dilute solutions the difference may
`be acceptably small.
`For example, a 0.9% w/v solution of
`sodium chloride in water contains 9 g of sodium chloride/L of
`solution, equivalent to 0.308 osmolar; or 9 g ofsodium chlo-
`ride/996.5 g of water, equivalent to 0.309 osmolal, less than a
`1% error.
`« For concentrated solutions the % difference be-
`tween osmolarity and osmolality is much greater and may be
`highly significant; 3.5% for 5% w/v dextrose solution and
`25% for 25% w/v dextrose solution. One should-be alerted
`to the sizable errors which may occur with concentrated_ solu-
`tions or fluids, such as those employed in total parenteral
`nutrition, enteral hyperalimentation and oral nutritional fluids
`for infants.
`.
`r
`.
`:
`,
`.
`,
`Reference has been made to the terms hypertonic and
`hypotonic. Analogous terms are hyperosmotic and hypo-
`osmotic. Assuming normal serum osmolality to be 285 mOs-
`mol/kg, .as serum osmolality increases due to water deficit,
`the following signs and symptoms usually are found to accu-
`mulate progressively at approximately these values;
`294 to
`298—thirst (if thepatient is alertand communicative); 299 to
`3l3—dry mucous membranes; 314 to 329———weakness,
`doughy skin; above 330——disorientation, postural hypoten-
`sion, severe weakness, fainting, CNS ‘changes, stupor and
`coma. As serum osmolality decreases due .,to water excess
`the following may occur: I 275 to , 26l—headache; 262 to
`251-drowsiness, weakness; 250 to 233'+disorientation,
`cramps; below 233—seizures, stupor and coma.
`J
`’
`'
`As indicated previously, the mechanisms of the bo_dyac-
`tively corn at such major changes by limiting the variation i_n
`osmolality,
`' r normal individualsto less than_about 1% (ap-
`proximatelifiglin the range 282 to 288 mOsmol/kg, based on the
`above assumption).
`'
`,
`_
`The value given for normal serum osmolality above was
`described as an‘ assumption because of the variety of values
`found ‘in the literature. Serum ‘osmolality often is stated
`loosely to be about 300 mOsmol/L. Various references re-
`port 280 to 295 mOsmol‘/L, 275 to 300 mOsmol/L, 290
`, mOsmol/L,’ 306 mOsmol/L and 275 to 295,mOsrnol/kg.
`‘
`Reference has been made to confusion _in -the use of the
`terms osmolality and osmolarity, a distinction of special impor-
`tance for nutritional fluids. Awareness of high ‘concentra-
`tions of infant-formula should give warning as to possible
`risks. Unfortunately, the osmoticity of infant formulas, tube
`feedings and total parenteral nutrition solutions has riot been
`described adequately either in textbooks or inthe literature',3
`and the labels of many commercial nutritional fluids do not,- in
`any way, state their osmoticity. Only recently have enteral
`fluids been characterized in terms of osmoticity. Some prod-
`uct lines _now are acceriting isoosmotic enteral nutritional
`supplements. Often, when the term osmolarity is used, one
`cannot discern whether this simply is incorrect terminology,
`or if osmolarity actually has been calculated from osmolality.
`Another currentpractice which ‘can cause confusion, is the
`use of the terms normal and/or physiological for isotonic
`sodium -chloride solution (0.9%). The solution surely is
`isoosmotic. However, as to being physiological, the concen-
`tration of ions are each of 154 mEq/L while-serum contains
`about 140 mEq of sodium and about 103 mEq of chloride.
`The range of mOsmol values found for‘ serum raises the
`question as to what really is meant by the terms hypotonic and
`hypertonic for medicinal and nutritional fluids. One can find
`the statement that fluids with an osmolality of 50 mOsmol or
`more above normal are hypertonic and, if 50 mOsmol or more
`below normal, are hypotonic. One also can find the state-
`ment that peripheral infusions should not have an osmolarity
`exceeding 700 to 800 mOsmol/L.4 Examples ‘of osmol con-
`centrations of solutions used in peripheral infusions are:
`(D5VV) 5% dextrose solution—252 mOsmol/L; (D1OW)«10%
`
`dextrose solution—505 mOsmol/L; Lactated Ringer’s 5% Dex-
`trose—-—525 mOsmol/L. When afluid is hypertonic, undesir-
`able effects often can be decreased by using relatively slow
`rates of infusion, and/or relatively short periods of infusion.
`25% dextrose solution (D25W)+4.25% Amino Acids is a
`representative example of a highly osmotic hyperalirnentation
`solution.
`It has been stated that when osmolal loading is
`needed, a maximum safe tolerance for a normally hydrated
`subject would be an approximate increase of 25 mOsmol/kg
`of water over 4 hours.3
`
`Computation of osmolarity
`
`‘Several methods are used to obtain numerical values of
`osmolarity. The osmolar concentration, sometimes referred
`to as the “theoretical osmolarity,” is calculated from the w /2)
`concentration using the following equation:
`
`1000 mOsmol _mOsmol
`‘osmol
`_
`L
`
`_
`osmol -
`mols
`(1)
`X mol X
`g
`L X
`The number of osmols/mol is equal to 1 for nonelectrolytes
`and is equal to the number of ions per molecule for stron
`A
`electrolytes.
`This calculation, omits consideration of factors such as
`solvation and interionic forces. By this method of calcula-
`tion 0.9% sodium chloride has an osmolar concentration of
`308 mOsmol/L and ahconcentration of 154 mOsmol/L in
`either sodium or chloride ion.
`- Two-other methods compute osmolarity from values of
`osmolality. The determination of osmolality will be dis-
`cussed later. One method has a strong theoretical basis of
`physical-chemical principles? using values of the partial molal
`volume(s) of the solute(s). A 0.9% sodium chloride solution,
`found experimentally to have an osmolality of 286 mOsmo1/
`kg, was calculatedito have an osmolarity of 280 mOsmol/L,
`rather different from the value of 308 mOsmol/L calculated as
`above. The method, using partial molal volumes, is rela-
`tively rigorous, but many systems appear to be too complex
`and/ or too poorly defined to be dealtwith by this method.
`The,other method is based on calculating the weight of
`water from the solution density and concentration
`
`,
`
`g water
`mL solution
`
`" g solute
`’
`’ g solution
`=mL solution mL solution
`
`then
`
`'
`
`osmolarity (
`
`VmOsIno1
`L solution ’
`
`,
`
`= osmolality (
`
`mOsmol
`1000 g water
`
`‘
`
`2 gwater 0.
`X mL solution
`
`The experimental value for theosmolality of 0.9% sodium
`chloride solution was 292.7 mOsmol/kg; the value computed
`for osmolarity was 291.4 mOsmol/ L. This method uses eas-
`ily obtained Values of density of the solution and of its solute
`content and can be used with all systems. For example, the
`osmolality of a nutritional product was determined by the
`freezing-point depression method to be 625 mOsmol/kg;7 its
`osmolarity was. calculated as 625 X 0.839 = 524 mOsmol/L.
`Monographs in the USP for solutions which provide intrave-
`nous replenishment of fluid, nutrient(s) or electrolyte(s), and
`for osmotic diuretics.-such as Mannitol Injection, require the
`osmolar concentration be stated on the label in osmols/L,
`except that where the contents are less than 100 mL, or where
`the -label states the article is not for direct injection but is to be
`diluted before use, the label alternatively may state the total
`osmolar concentration in mOsmol/ mL.
`‘
`’
`.
`.
`
`An example of the use of the first method‘ described above is the
`comp'utation’of the approximate osmolar concentration (“theoretical os-
`molarity”) of a Lactated Ringer's 5% Dextrose Solution (Abbott), which is
`labeled to contain, per L, dextrose (hydrous) 50 g, sodium chloride 6 g,
`potassium chloride 300 mg, calcium chloride 200 mg and sodium lactate
`
`0006
`
`0006
`
`

`
`616
`
`CHAPTER 36
`
`3.1 g. Also stated is that the total osmolar concentration of the solution is
`approximately 524 m0smol per L, in part contributed by 130 mEq of Na*,
`.109 mEq of Cl‘, 4 mEq of K‘', 3 mEq of Ca2+ and 28 mEq of lactate ion.
`The derivation of the osmolar concentrations from the stated composi-
`tion of the solution may be verified by calculations using Eq 1.
`Dextrose.
`
`0 1000 mOsmol
`X
`Osmol
`
`= 252 mOsmol/L
`
`><
`
`1000 mOsmol
`osmol
`
`50g
`1 osmol
`1 mol
`_L X198gX mol
`Sodium Chloride
`1 mol
`2 osmol
`
`L
`
`58.4 g X mol
`
`5 mosmol
`L
`
`(102.7 m0smol Na‘“)
`(102.7 m0smol or)
`
`Potassium Chloride
`2 osmol
`.1 mol
`mol
`74.6 g
`
`X
`
`x
`
`1000 mOsmol
`osmol
`
`Calcium Chloride
`
`8.04 mOsmol I4-02 m05m01K+)
`L
`(4.02 mOsmol or)
`
`_
`
`3 osmol
`0.2 g ' 1 mol
`L
`X 111 g X mol
`
`X
`
`1000 mOsmol
`osmol
`
`541 mom, V (1.30 mosmol Ca2+)
`L
`(3.61 mOsmol 01-)
`
`_
`
`Sodium Lactate
`
`3.1g
`L
`
`2osmol
`lmol
`X 112 g X mol
`
`x
`
`1000 mosmoi
`, osmol
`
`55.4 mOsmol.[(27-7 m0sm0.1Na*)
`
`(2 7. 7 m0smol lactate)
`
`L
`
`The total osmolar concentration of the five solutes in the solution is 526,
`in good agreement with the labeled total osmolar concentration of approxi-
`mately 524 mOsmol/L.
`,
`The mOsmol of sodium in 1 L of the solution is the sum ofthe mOsmol of
`the ion from sodium chloride and sodium lactate, ie, 102 + 27.6 = 129.6
`mOsmol. Chloride ions come from the sodium chloride, potassium chlo-
`ride and calcium chloride, the total osmolar concentration being 102 +
`4.02 + 3.6 1 = 1 09.6 mOsmol. The m‘Osrnol values of potassium, cal-
`cium and lactate are calculated to be 4.02, 1.80 and 27.6, respectively.
`
`The osmolarity of a mixture of complex composition, such
`as an enteral hyperalimentation fluid, cannot be calculated
`with any acceptable degree of certainty and, therefore, the
`osmolality of such preparations should be determined experi-
`mentally.
`“
`
`Undesirable Effects of Abnormal Osmoticity
`
`Ophthalmic Medication—It is generally accepted that
`ophthalmic preparations intended for instillation into the cul-
`de-sac of the eye should, if possible, be approximately iso-
`tonic to avoid irritation (see Chapter 89).
`It also has been
`stated that the abnormal tonicity of contact lens solutions can
`cause the lens to adhere to the eye and/ or cause burning or
`dryness and photophobia.
`-
`Parenteral Medication—-Osmoticity is of great impor-
`tance in parenteral injections, its effects depending on the
`degree of deviation from tonicity, the concentration, the loca-
`tion of the injection, the volume injected, the speed of the
`injection, the rapidity of dilution and difiusion, etc. When
`formulating parenterals, solutions otherwise hypotonic usu-
`ally have their tonicity adjusted by the addition of dextrose or
`sodium chloride. Hypertonic parenteral drug solutions can-
`not be adjusted. Hypotonic and hypertonic solutions usually
`are administered slowly in small volumes, or into a large vein
`such as the subclavian, where dilution and distribution occur
`rapidly. Solutions that differ from the serum in tonicity gen-
`
`erally are stated to cause tissue irritation, pain on injection
`and electrolyte shifts, the effect depending on the degree of »
`deviation from tonicity.
`-
`.
`.
`Excessive infusion of hypotonic fluids may cause swelling
`of red blood cells, hemolysis and water invasion of the body's
`cells in general. When this is beyond the body‘s tolerance for
`water, water intoxication results, with convulsions and edema,
`such as pulmonary edema.
`1.
`Excessive infusion of isotonic fluids can cause an increase
`in extracellular fluid volume, which can result in circulatory
`overload.
`1
`'
`‘
`Excessive’ infusion of hypertonic fluids leads to awide
`variety of complications. For example, the sequence of
`events when the body is presented with a large intravenous
`load of hypertonic fluid, rich in dextrose,
`is as follows:
`hyperglycemia, glycosuria and intracellular dehydration, os-
`motic diuresis, loss of water and electrolytes, dehydration and
`coma.
`One cause of osmotic diuresis is the infusion of dextrose at a
`rate faster than the ability of the patient to metabolizeit (as
`greater than perhaps 400 to 500 mg/kg/hr for an adult on
`total parenteral nutrition). A heavy load of unmetabolizable
`dextrose increases the osmoticity of blood and acts as a di-
`uretic; the increased solute load requires more fluid for excre-
`tion, 10 to 20 mL of waterbeing required to excrete each gram
`of dextrose. Solutions, such as those for total parenteral
`nutrition, should be administered by means of a metered
`constant-infusion apparatus over a lengthy period (usually
`more than 24 hours) to avoid sudden hyperosmotic dextrose
`loads.
`Such solutions may cause osmotic diuresis; if this 1
`occurs, water balance is likely to become negative because of
`the increased urinary volume, and electrolyte depletion may
`occur because of excretion of sodium and potassium second-
`ary to the osmotic diuresis.
`If such diuresis is marked, body
`weight falls abruptly and signs of dehydration appear. Urine
`should be monitored for signs of osmotic diuresis, such as
`glycosuria and increased urine volume.
`‘
`k»(
`If the intravenous injection rate of hypertonic so ntion is too
`rapid, there may be catastrophic effects on the circulatory and
`respiratory. systems. , Blood pressure may fall_ tohangerous
`levels, cardiac irregularities or arrest may ensue, respiration
`may "become shallow and ‘irregular and there may be heart
`failure and pulmonary edema. Probably the precipitating
`factor is a bolus of concentrated solute suddenly reaching the
`myocardium and the chemoreceptors in the aortic arch and
`carotid sinus.3
`0
`0
`'
`Abrupt changes in serum osmoticity can lead to cerebral
`hemorrhage.
`It has been shown experimentally that rapid
`infusions of therapeutic doses of hypertonic saline with os-
`motic loads produce a sudden rise in cerebrospinal fluid (CSF)
`pressure and venous pressure (VP) followed by a precipitous
`fall in CSF pressure. This particularly may be conducive to
`intracranial hemorrhage, as the rapid infusion produces an
`increase in plasma volume and venous pressure at the same
`time the CSF pressure is falling. During the CSF pressure
`rise, there is a drop in hemoglobin and hematocrit, reflecting a
`marked increase in blood volume.
`Hyperosmotic medications, such as sodium bicarbonate
`(osmolarity of 1560 at 1 mEq/mL), which are administered
`intravenously, should be diluted prior to use and should be
`injected slowly to allow dilution by the circulating blood.
`Rapid “pus ” injections may cause a significant increase in
`blood osmoticity.5
`.

`'
`As to other possibilities, there may be crenation of red blood
`cells and general cellular dehydration. Hypertonic dextrose
`or saline, etc, infused through a peripheral vein with small
`blood volume may traumatize the vein and cause
`thrombophlebitis.
`Infiltration can cause trauma and necro-
`sis of tissues. Safety, therefore, demands that all intrave-
`nous injections, especially highly osmotic solutions, bevper-
`formed slowly, usually being given preferably over a period
`not less than that required for a complete circulation of the
`blood, eg, 1 minute. The exact danger point varies with the
`
`0007
`
`0007
`
`

`
`TONICITY, OSMOTICITY, OSMOLALITY AND OSMOLARITY
`
`617
`
`state of the patient, the concentration‘ of the solution, the
`nature of the solute and the rate of, administration. ‘
`Hyperosmotic solutions also should not be discontinued
`suddenly.
`In dogs, marked increase in levels of intracranial
`pressure occur when hyperglycemia produced by dextrose
`infusions is reversed suddenly by stopping the infusion and
`administering saline.
`It also has been shown that the CSF
`pressure in humans rises during treatment of diabetic ketoaci-
`dosis in association with a fall in the plasma concentration of
`dextrose and a fall in plasma osmolality. These observations
`may be explained by the different rates of decline in dextrose
`content of the brain andof plasma. The conc,entration' of
`dextrose in the brain may fall more slowly than in the plasma,
`causing a shift of fluid from the extracellularfluid space to the
`intracellular compartment of the CNS, resulting in increased
`intracranial pressure.
`
`Osmometry and the Clinical Laboratory
`
`Serum and urine osmometry may assist in the diagnosis of
`certain fluid and electrolyte problems. However, osmometry
`values have little meaning unless the clinical situation is known.
`Osmometry is used in renal dialysis as a check on the electro-
`lyte composition of the fluid.
`In the clinical laboratory, as
`stated above, the term ’ "osmo

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket